Online inquiry

IVTScrip™ mRNA-Human Acetylcholinesterase, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK12424MR)

This product GTTS-WK12424MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the Acetylcholinesterase protein. This product can be used in Cholinergic neuron-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_000665.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 43
UniProt ID P22303
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human Acetylcholinesterase, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK12424MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK14166MR IVTScrip™ mRNA-Human ABHD17A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ABHD17A
GTTS-WK14472MR IVTScrip™ mRNA-Human AKR1A1, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA AKR1A1
GTTS-WK3317MR IVTScrip™ mRNA-Human PHEX, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA PHEX
GTTS-WK12622MR IVTScrip™ mRNA-Human AASDHPPT, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA AASDHPPT
GTTS-WK0555MR IVTScrip™ mRNA-Human CD45RA, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA CD45RA
GTTS-WK8950MR IVTScrip™ mRNA-Human ADH7, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADH7
GTTS-WK26941MR IVTScrip™ mRNA-Human ATAD5, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ATAD5
GTTS-WK25439MR IVTScrip™ mRNA-Human ATAD3B, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ATAD3B
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW